Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 45 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase II-III Therapy with 5-FU vs 5-FU/TZT vs 5-FU/ICRF-159 vs MeCCNU/ICRF-159 vs MeCCNU/TZT vs ICRF-159/TZT for Advanced Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified				NCI				NCCTG-784651

Last Modified: 4/12/2006


2.		Phase II/III Chemotherapy with FAP (5-FU/ADR/CACP) vs FAT (5-FU/ADR/TZT) vs FAMe (5-FU/ADR/MeCCNU) in Metastatic or Unexplored Gastric Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified								GITSG-8380

Last Modified: 7/1/1990


3.		Phase II/III Combination Chemotherapy with FAME (5-FU/ADR/MeCCNU) vs FAP (5-FU/ADR/CACP) vs FAME Alternating with TZT vs 5-FU Alone for Advanced Gastric Carcinoma (Summary Last Modified 07/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				18 and over				NCI				NCCTG-834151 MAYO-834151, NCCTG-83-41-51


4.		Phase II-III Chemotherapy with Ftorafur vs 5-FU/MeCCNU/TZT vs 5-FU/MeCCNU/ICRF-159 vs 5-FU/MeCCNU/VCR for Advanced Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified								MAYO-764802

Last Modified: 4/1/1988


5.		Phase I/II Pilot Study of Chemotherapy with MITOC/TZT/CDDP in Patients with Advanced Gastrointestinal Cancer (Summary Last Modified 04/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 and over				NCI				MAYO-860302 NCI-T86-0204H, T86-0204


6.		Phase I-II Chemotherapy with CTX, ADR, DAG, VP-16, PZD and TZT for Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				no age specified								MAYO-750302


7.		Phase I/II Optimal Dose Level Pilot Study of 5-FU, ICRF-159, MeCCNU plus Triazinate in Various Two-Drug Combinations for Large Bowel Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				no age specified								MAYO-770304


8.		Phase II Chemotherapy with TZT for Metastatic Cancer of Breast, Lung, Head & Neck, GI Tract, Genitourinary System, and Gynecologic System

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								NCI-D78-048-054 WCCC-CO-7792


9.		Phase II Chemotherapy with Baker's Antifol for Leukemia or Solid Tumors in Children

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				under 21				NCI				POG-7605

Last Modified: 5/3/2006


10.		Phase II Adjuvant Chemotherapy with CLZ, TZT, CACP, or BCNU/5-FU for Intracranial Neoplasms

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 15								BTSG-7820

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute